Membrane attack complex
Template:Infobox protein complex
The Membrane Attack Complex (MAC) is a structure formed on the cell membranes of bacteria and other pathogens that leads to cell lysis and death. It is part of the immune system's defense mechanism, specifically the complement system, which is a component of the innate immune system. The MAC is the final product of the complement cascade, which is initiated to help defend against microbial infections.
Structure and Formation[edit | edit source]
The MAC is composed of several complement proteins, including C5b, C6, C7, C8, and multiple copies of C9. The formation of the MAC begins when the complement protein C5 convertase cleaves C5 into C5a and C5b. C5b then binds to C6 and C7, which insert into the cell membrane. C8 joins and anchors the complex more firmly into the membrane. Finally, C9 molecules polymerize and form a pore in the membrane, known as the MAC pore.
Function[edit | edit source]
The primary function of the MAC is to disrupt the phospholipid bilayer of target cells, leading to cell lysis and death. This is crucial in the body's defense against pathogens, particularly bacteria and virus-infected cells. By forming pores in the membranes of these cells, the MAC causes an influx of water and ions, leading to osmotic swelling and eventual cell rupture.
Clinical Significance[edit | edit source]
Abnormal regulation of MAC formation can lead to tissue damage and is implicated in various diseases. For example, excessive or uncontrolled MAC formation is a factor in some types of autoimmune diseases and inflammatory conditions. Conversely, insufficient MAC activity can lead to increased susceptibility to infections.
Regulation[edit | edit source]
The activity of the MAC is regulated by several proteins to prevent damage to host cells. Proteins such as CD59 and protectin inhibit the formation of the MAC by preventing the recruitment of C9, thus protecting host cells from unintended complement activation and damage.
Research and Therapeutics[edit | edit source]
Research into the MAC has led to the development of therapeutic interventions that modulate the activity of the complement system. These therapies are aimed at treating diseases caused by excessive complement activation, such as atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH).
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD